139 episodes

New research and clinical trials yield frequent developments in neuroscience and mental health. ReachMD welcomes an array of leading thinkers who lend their focused expertise to these principles, central to human function and ability.

Focus on Neurology and Psychiatry ReachMD

    • Science
    • 3.9 • 35 Ratings

New research and clinical trials yield frequent developments in neuroscience and mental health. ReachMD welcomes an array of leading thinkers who lend their focused expertise to these principles, central to human function and ability.

    Staying Ahead of Progression in RMS

    Staying Ahead of Progression in RMS

    Guest: Timothy William West, MD


    Here to discuss staying ahead of progression in patients with relapsing multiple sclerosis (RMS) is Dr. Timothy William West. Dr. West walks us through pathophysiological changes in progressing RMS patients, a patient case demonstrating why patients may experience increasing disability, and key data on MAYZENT®(siponimod), the first and only oral disease-modifying therapy studied and proven to delay disability progression in a more progressed RMS patient population, including active SPMS.
    MAYZENT was evaluated in EXPAND—the largest Phase III study of secondary progressive MS (SPMS) patients to date (N=1651), which included a broad range of patients with moderate-to-advanced disability. Dr. West discusses clinical data from EXPAND including data of up to 5 years from a preplanned interim analysis of the EXPAND open-label extension study.

    Investigating the Adoption of Behavioral Health Integration

    Investigating the Adoption of Behavioral Health Integration

    Host: Jennifer Caudle, DO

    Guest: Kathleen Blake, MD, MPH

    Guest: Peggy Chen, MD


    Behavioral health integration has proven to be an effective solution to improving access to treatment for many mental health conditions… So why is it not more prevalent in the medical community? Joining Dr. Jennifer Caudle to dive into the findings and implications of the joint AMA-RAND Corporation study recently published in the Annals of Internal Medicine are Dr. Kathleen Blake with the AMA and Dr. Peggy Chen from the RAND Corporation.
    And, click here to listen to a conversation regarding Behavioral Health Integration and its effect on clinical practice.

    Bipolar Disorder: Pathophysiology and Comorbidities

    Bipolar Disorder: Pathophysiology and Comorbidities

    Guest: Andrew Cutler, MD


    In Chapter 1 of this three-part series that’s designed to help increase the awareness and understanding of the pathophysicology and comorbidities in patients with bipolar disorder or schizophrenia, Dr. Cutler explores the pathophysicology and some comorbidities in patients with bipolar disorder.
    This is an informational non-CME program sponsored by Alkermes, Inc. ALKERMES® is a registered trademark of Alkermes, Inc. KEEP THE BODY IN MIND® is a registered service mark of Alkermes Pharma Ireland Limited, used by Alkermes, Inc., under license. ©2020 Alkermes, Inc. All rights reserved.
    None of the subjects pictured are actual patients.
    UNB-002745

    Schizophrenia: Pathophysiology and Comorbidities

    Schizophrenia: Pathophysiology and Comorbidities

    Guest: Andrew Cutler, MD


    Take a closer look at the pathophysiology of schizophrenia and a range of physical comorbidities with Dr. Cutler in Chapter 2 of this three-part series for the “Keep the Body in Mind” initiative.
    This is an informational non-CME program sponsored by Alkermes, Inc. ALKERMES® is a registered trademark of Alkermes, Inc. KEEP THE BODY IN MIND® is a registered service mark of Alkermes Pharma Ireland Limited, used by Alkermes, Inc., under license. ©2020 Alkermes, Inc. All rights reserved.
    None of the subjects pictured are actual patients.
    UNB-002974

    Opportunities to Manage the Whole Patient with Bipolar Disorder or Schizophrenia

    Opportunities to Manage the Whole Patient with Bipolar Disorder or Schizophrenia

    Guest: Andrew Cutler, MD


    In the third and final chapter of this series for the “Keep the Body in Mind” initiative, Dr. Cutler discusses strategies that could improve care for patients with bipolar disorder or schizophrenia and talks about recommendations for evaluating and monitoring health conditions.
    This is an informational non-CME program sponsored by Alkermes, Inc. ALKERMES® is a registered trademark of Alkermes, Inc. KEEP THE BODY IN MIND® is a registered service mark of Alkermes Pharma Ireland Limited, used by Alkermes, Inc., under license. ©2020 Alkermes, Inc. All rights reserved.
    None of the subjects pictured are actual patients.
    UNB-002975

    Keys to Avoiding an Adrenoleukodystrophy Misdiagnosis

    Keys to Avoiding an Adrenoleukodystrophy Misdiagnosis

    Host: Mario R. Nacinovich, Jr., MSc

    Guest: Paul Orchard, MD


    Although it only affects about one in 18,000 people, the impacts of adrenoleukodystrophy cannot be underestimated. That’s why Dr. Paul Orchard joins Mario Nacinovich to talk about this rare—and fatal—genetic disease, why it’s often underdiagnosed and confused with other conditions, and how we can treat it once we’ve reached an accurate diagnosis.

Customer Reviews

3.9 out of 5
35 Ratings

35 Ratings

Top Podcasts In Science

Listeners Also Subscribed To

More by ReachMD